SabahEquityResearch

My high-net-worth investor bets big on six EV stocks.

Long
BATS:TSLA   Tesla
I recently collaborated on a portfolio with a highly successful businessman who is passionate about the electric vehicle (EV) space. We opted for a long-only EV portfolio, allocating a total of $69,000, a number that our client believes holds significance value to him.

The allocation is as follows:

TSLA (Tesla) - 50%: The undisputed king of EVs, Tesla holds a dominant position in the market, making it a core component of the portfolio.

XPEV (Xpeng Motors) - 15%: A strategic joint venture with Audi, Xpeng is a formidable player in the Chinese EV market, offering innovative and competitive vehicles.

NIO (Nio) - 15%: Dubbed the "Chinese Mercedes," Nio is a rising star in the EV industry, known for its sleek designs and advanced technology.

LI (Li Auto) - 10%: The leader of the Chinese EV pack, Li Auto has captured market share with its innovative SUV model, offering a unique blend of practicality and luxury.

RIVN (Rivian) - 10%: Backed by Amazon founder Jeff Bezos, Rivian is poised to make a significant impact in the EV truck segment.

We consciously excluded VFS (VinFast) from the portfolio, considering it a potential pump-and-dump scheme. But we are willing to invest in this scheme once the time is right.

A Message from Aladdin: The Master mind behind this tactical investment.

My philosophy is that "diversification is for losers," I believe that focusing on a select few high-potential stocks can lead to superior returns. While this approach carries inherent risks, it aligns with my risk tolerance and investment goals.
Trade active:
All the trades are executed. These stocks are at a very very promising spot to get in.
Comment:
if you are not in yet you will likely miss out on the upcoming rally.



I wont be providing ideas and updates in Tradingview any more. I have 20+ new students to work with in Sabah Trading Room. Updates on the positions will be given in the trading room.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.